Heart disease kills 18 million people each year, but the development of new therapies faces a bottleneck: no physiological model of the entire human heart exists – so far. A new multi-chamber organoid ...

New ACC/AHA guidelines update management of adults with congenital heart defects but highlight the shortage of specialists ...

Cardiovascular diseases (CVDs) remain the leading cause of death worldwide. Several risk factors, including genetics, sex, and age, increase the risk of CVDs. Other factors that contribute to CVD ...

An advanced human heart organoid system can be used to model embryonic heart development under pregestational diabetes-like conditions, researchers report. The organoids recapitulate hallmarks of ...

Having explored how the heart is formed in utero, a University of Houston pharmacology researcher is reporting how cells and molecules act during that early formation and what might cause the heart ...

Share on Pinterest Research shows that poor heart health may put people at risk of multiple musculoskeletal disorders. Ronald Martinez/Getty Images Researchers investigated the link between ...

An international team of researchers has discovered a natural mechanism that protects the heart from heart failure with preserved ejection fraction (HFpEF), a serious condition in need of effective ...

Heart disease kills 18 million people each year, but the development of new therapies faces a bottleneck: no physiological model of the entire human heart exists – so far. A new multi-chamber organoid ...

Using a combination for spatial, single-cell transcriptomics and imaging data from 36 hearts, scientists from the KTH Royal Institute of Technology and their collaborators have come up with what they ...

Tenaya Therapeutics (TNYA) is a very interesting biotech because it is in the process of developing two one-time gene therapies to treat patients with common genetic heart disorders. I believe that ...